Last reviewed · How we verify
Physician's Choice medications — Competitive Intelligence Brief
phase 3
Physician's Choice
Multiple Therapeutic Areas
Small molecule
Live · refreshed every 30 min
Target snapshot
Physician's Choice medications (Physician's Choice medications) — Swedish Orphan Biovitrum. Physician's Choice medications are a class of treatments that provide a choice between different medications for a specific condition.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Physician's Choice medications TARGET | Physician's Choice medications | Swedish Orphan Biovitrum | phase 3 | Physician's Choice |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Physician's Choice class)
- Swedish Orphan Biovitrum · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Physician's Choice medications CI watch — RSS
- Physician's Choice medications CI watch — Atom
- Physician's Choice medications CI watch — JSON
- Physician's Choice medications alone — RSS
- Whole Physician's Choice class — RSS
Cite this brief
Drug Landscape (2026). Physician's Choice medications — Competitive Intelligence Brief. https://druglandscape.com/ci/physician-s-choice-medications. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab